Epilepsy Trials in Chicago, United States
Conditions / Epilepsy / Chicago, United States
Epilepsy is a medical condition with active clinical research programs worldwide.
52 total trials for this combination
Showing top 10 of 52 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00113165 | Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures | COMPLETED | PHASE3 |
| NCT00334958 | Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures | COMPLETED | PHASE3 |
| NCT00464269 | Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures | COMPLETED | PHASE3 |
| NCT01339559 | Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy | COMPLETED | PHASE3 |
| NCT01999777 | Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU | COMPLETED | PHASE3 |
| NCT00150800 | This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment | COMPLETED | PHASE3 |
| NCT01390220 | Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters | TERMINATED | PHASE3 |
| NCT01730170 | Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) | COMPLETED | — |
| NCT00113815 | Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures | COMPLETED | PHASE3 |
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | COMPLETED | — |